Department of Cardiology, Providence-Providence Park Hospital/Michigan State University College of Human Medicine, Southfield, MI, USA.
Department of Cardiology, Providence-Providence Park Hospital/Michigan State University College of Human Medicine, Southfield, MI, USA.
Int J Cardiol. 2018 Dec 1;272:179-184. doi: 10.1016/j.ijcard.2018.08.017. Epub 2018 Aug 10.
To evaluate the effectiveness of wearable cardioverter defibrillator (WCD) use in protecting patients from sudden cardiac arrest (SCA) while they were treated in nonhospital settings until re-implantation of an Implantable cardioverter-defibrillator (ICD) was feasible. We sought to determine whether the WCD could be successfully utilized long term (≥1 year) after ICD extraction in patients at continued risk of SCD in which ICD re-implantation was not practical.
ICDs have proven to improve mortality in patients for both secondary and primary prevention of SCA. Increased ICD implantation in older patients with comorbid conditions has resulted in higher rates of cardiac device infections. Currently, a wearable cardioverter defibrillator (WCD) is an alternative management for SCA prevention in specific cases.
This a retrospective analysis based on consecutive WCD patients who underwent ICD explant due to device-related infections or mechanical reasons between April 2007 and July 2014. A total of 102 patients were identified from the national database maintained by ZOLL (Pittsburgh, PA, USA). We analyzed the reason for WCD use, demographic information, device data, compliance and duration of WCD use, detected arrhythmias and therapies, and reason for discontinuing WCD use.
In these long term WCD users, average length of WCD use was 638 ± 361 days. Nine patients (8.8%) had a sustained ventricular arrhythmia that was successfully resuscitated by the WCD. Six patients (5.8%) experienced inappropriate shocks. Two patients (1.9%) died of asystole events while wearing the WCD and an additional 10 patients died while not monitored by the WCD. Thirty-nine patients (38.2%) ended WCD use when a new ICD was implanted and 15 patients (14.7%) were still wearing the WCD at the time of analysis.
We found that extending use of the WCD to ≥1 year is a safe and effective alternative treatment for patients with explanted ICDs who are not pacemaker dependent.
评估可穿戴式除颤器(WCD)在非医院环境中对患者的有效性,以保护其免受心搏骤停(SCA)的影响,直至可植入式心脏复律除颤器(ICD)重新植入成为可能。我们试图确定在因心脏器械感染或机械原因而 ICD 取出的患者中,在继续存在 SCD 风险且 ICD 重新植入不切实际的情况下,WCD 是否能够长期(≥1 年)成功使用。
ICD 已被证明可提高 SCA 二级和一级预防患者的死亡率。患有合并症的老年患者中 ICD 植入的增加导致了更高的心脏器械感染率。目前,在某些特定情况下,可穿戴式除颤器(WCD)是预防 SCA 的替代管理方法。
这是一项基于连续 WCD 患者的回顾性分析,这些患者因器械相关感染或机械原因于 2007 年 4 月至 2014 年 7 月期间接受 ICD 取出。从美国宾夕法尼亚州匹兹堡的 ZOLL 维护的国家数据库中确定了 102 名患者。我们分析了 WCD 使用的原因、人口统计学信息、器械数据、合规性和 WCD 使用时间、检测到的心律失常和治疗以及停止使用 WCD 的原因。
在这些长期使用 WCD 的患者中,WCD 的平均使用时间为 638±361 天。9 名患者(8.8%)出现持续性室性心律失常,WCD 成功进行了复苏。6 名患者(5.8%)经历了不适当的电击。2 名患者(1.9%)在佩戴 WCD 时因停搏事件死亡,另外 10 名患者在未佩戴 WCD 时死亡。39 名患者(38.2%)在植入新 ICD 时停止使用 WCD,15 名患者(14.7%)在分析时仍佩戴 WCD。
我们发现,对于已取出 ICD 且无需起搏器的患者,将 WCD 的使用时间延长至≥1 年是一种安全有效的替代治疗方法。